Question follow-through · 125732

Motor Neurone Disease: Medical Treatments

To ask the Secretary of State for Health and Social Care, what recent discussions the UK Neuro Forum has had on (a) care pathways, (b) treatment options and (c) access to drugs for patients with motor neurone disease.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
10 Apr 2026
Target answer date
14 Apr 2026
Answer
27 Apr 2026 · 17 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 10 Apr 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, what recent discussions the UK Neuro Forum has had on (a) care pathways, (b) treatment options and (c) access to drugs for patients with motor neurone disease.

  2. 14 Apr 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 27 Apr 2026

    Answer published

    The UK Neuro Forum brings key stakeholders together to share learnings across the system and to discuss challenges, best practice examples, and potential solutions for improving the care of people with neurological conditions, including motor neurone dise...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Strong linkSame MP, department and exact heading

Motor Neurone Disease: Medical Treatments

13 Apr 2026 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the National Institute for Health and Care Research on the development of UK based research about (a) emerging drugs and (b) treatment options for patients with MND

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services

13 Apr 2026 · To ask the Secretary of State for Health and Social Care, whether he has had recent discussions with (a) NHS England and (b) integrated care boards on the potential impact of the adequacy of physical therapy services on patients' cognitive ability.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Contracts

14 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 March 2026 to Question 121056 on General Practitioners: Contracts, when the review of the Carr-Hill formula will conclude; and when he plans to publish its findings.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Rural Areas

14 Apr 2026 · To ask the Secretary of State for Health and Social Care, what steps will be taken to consider rural GP practices in the review of the Carr-Hill formula.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Contracts

15 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 March 2026 to Question 119478 on General Practitioners: Contracts, how he defines ‘avoiding’ in the context of avoiding 1.3 million patients being added to a waiting li

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Contracts

15 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 March 2026 to Question 120986 on General Practitioners: Contracts, if he will publish the evidence that shows that patients had improved care as a result of changes to

Unreviewed candidateSame MP and department; topic relationship is unreviewed

General Practitioners: Contracts

15 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 March 2026 to Question 120986 on General Practitioners: Contracts, what evidence his Department holds which shows that patients had improved care as a result of changes

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Patient Choice Schemes

16 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 March 2026 to WPQ 122758, whether his Department will stipulate who should be triaging in the Elective Single Point of Access Model.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Patient Choice Schemes

16 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 March 2026 to WPQ 122758, what professionals will be allowed to triage in the Elective Single Point of Access Model.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Patient Choice Schemes

16 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 March 2026 to WPQ 122758, whether there will be any limitations on what qualifications staff will be required to have in order to triage in the Elective Single Point of

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Patient Choice Schemes

16 Apr 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 March 2026 to WPQ 122758, if his Department will publish a list of all the (a) professional and (b) clinical criteria which staff will need to meet in order to triage i

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Crimes of Violence

16 Apr 2026 · To ask the Secretary of State for Health and Social Care, if he has made an assessment of the impact on his Department’s policies of Community Pharmacy England’s recently commissioned survey on abuse in pharmacies.